Cohen Fredric J. 4
4 · Strongbridge Biopharma plc · Filed Feb 22, 2019
Insider Transaction Report
Form 4
Cohen Fredric J.
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2019-02-20+24,500→ 37,934 total - Award
Employee Stock Option (right to buy)
2019-02-20+118,000→ 118,000 totalExercise: $4.67Exp: 2029-02-20→ Common Stock (118,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest in full on February 20, 2021, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests in sixteen equal quarterly installments beginning May 20, 2019, provided the Reporting Person is employed by the Issuer on each vesting date.